Chris Shaw
Shaw, Christopher A.
Shaw, Christopher A. (Christopher Ariel)
Shaw, Christopher Ariel
Shaw, Christopher Ariel, 19..-....
Shaw, Christopher A. (Christopher Ariel), 1950-
VIAF ID: 4189027 (Personal)
Permalink: http://viaf.org/viaf/4189027
Preferred Forms
- 100 0 _ ‡a Chris Shaw
- 200 _ | ‡a Shaw ‡b Christopher A.
-
-
- 100 1 _ ‡a Shaw, Christopher A.
- 100 1 _ ‡a Shaw, Christopher A. ‡q (Christopher Ariel)
- 100 1 _ ‡a Shaw, Christopher A. ‡q (Christopher Ariel)
-
-
- 100 1 _ ‡a Shaw, Christopher Ariel
- 100 1 _ ‡a Shaw, Christopher Ariel, ‡d 19..-....
4xx's: Alternate Name Forms (6)
5xx's: Related Names (1)
Works
Title | Sources |
---|---|
[11C]-WAY100635 PET demonstrates marked 5-HT1A receptor changes in sporadic ALS. | |
Biomechanical implications of the variation in Smilodon ectocuneiforms from Rancho La Brea | |
Five ring circus : myths and realities of the Olympic Games | |
Glutathione in the nervous system | |
Mapping of gene expression reveals CYP27A1 as a susceptibility gene for sporadic ALS. | |
Mechanisms of aluminum adjuvant toxicity and autoimmunity in pediatric populations. | |
Modeling Environmentally-Induced Motor Neuron Degeneration in Zebrafish. | |
Mutant induced pluripotent stem cell lines recapitulate aspects of TDP-43 proteinopathies and reveal cell-specific vulnerability | |
Neural dynamics of neurological disease | |
Neurofilament subunit | |
Neuromuscular disease: new insights and avenues for therapy. | |
No autoimmune safety signal after vaccination with quadrivalent HPV vaccine Gardasil? | |
No evidence for a large difference in ALS frequency in populations of African and European origin: a population based study in inner city London | |
Non-linear dose-response of aluminium hydroxide adjuvant particles: Selective low dose neurotoxicity | |
Non-nuclear Pool of Splicing Factor SFPQ Regulates Axonal Transcripts Required for Normal Motor Development | |
Nuclear import impairment causes cytoplasmic trans-activation response DNA-binding protein accumulation and is associated with frontotemporal lobar degeneration | |
Nutritional factors associated with survival following enteral tube feeding in patients with motor neurone disease | |
Optineurin inclusions occur in a minority of TDP-43 positive ALS and FTLD-TDP cases and are rarely observed in other neurodegenerative disorders | |
p62 positive, TDP-43 negative, neuronal cytoplasmic and intranuclear inclusions in the cerebellum and hippocampus define the pathology of C9orf72-linked FTLD and MND/ALS | |
Panax ginseng is neuroprotective in a novel progressive model of Parkinson's disease | |
PARADOXICAL RESPONSES TO NEUROTOXIC STERYL GLYCOSIDES: INSIGHTS FROM A CELLULAR MODEL OF ALSPDC. | |
Parkinson-dementia complex and development of a new stable isotope dilution assay for BMAA detection in tissue | |
Phenotypic Characteristics as Predictors of Phytosterols in Mature Cycas micronesica Seeds. | |
Phosphorylation of C-terminal tyrosine residue 526 in FUS impairs its nuclear import. | |
Polymorphisms in the GluR2 gene are not associated with amyotrophic lateral sclerosis | |
The primary locus of motor neuron death in an ALS-PDC mouse model | |
Progranulin is expressed within motor neurons and promotes neuronal cell survival | |
The Progressive BSSG Rat Model of Parkinson's: Recapitulating Multiple Key Features of the Human Disease | |
Proteomic analyses reveal that loss of TDP-43 affects RNA processing and intracellular transport | |
Psychological as well as illness factors influence acceptance of non-invasive ventilation | |
Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease | |
Receptor dynamics in neural development, 1996: | |
Recessive amyotrophic lateral sclerosis families with the D90A SOD1 mutation share a common founder: evidence for a linked protective factor | |
Reduction in hSOD1 copy number significantly impacts ALS phenotype presentation in G37R (line 29) mice: implications for the assessment of putative therapeutic agents | |
Relative preservation of triceps over biceps strength in upper limb-onset ALS: the 'split elbow' | |
Remarkable motor recovery after riboflavin therapy in adult-onset Brown-Vialetto-Van Laere syndrome. | |
Removal notice to "Subcutaneous injections of aluminum at vaccine adjuvant levels activate innate immune genes in mouse brain that are homologous with biomarkers of autism" [Journal of Inorganic Biochemistry 177 (2017) 39-54]. | |
Reply | |
Residual association at C9orf72 suggests an alternative amyotrophic lateral sclerosis-causing hexanucleotide repeat | |
Retention of hexanucleotide repeat-containing intron in C9orf72 mRNA: implications for the pathogenesis of ALS/FTD | |
RETRACTED: Letter to the editor "[Toxicology (2017) 159 -159] | |
The role of variation at AβPP, PSEN1, PSEN2, and MAPT in late onset Alzheimer's disease | |
Senataxin, the ortholog of a yeast RNA helicase, is mutant in ataxia-ocular apraxia 2. | |
A serum microRNA signature for amyotrophic lateral sclersosis reveals convergent RNA processing defects and identifies presymptomatic mutation carriers. | |
The sex ratio in amyotrophic lateral sclerosis: A population based study. | |
Skeletal trauma reflects hunting behaviour in extinct sabre-tooth cats and dire wolves | |
Smilodon : the iconic sabertooth | |
Spectrums of amyotrophic lateral sclerosis : heterogeneity, pathology, and therapeutic directions | |
Survival of patients with ALS following institution of enteral feeding is related to pre-procedure oximetry: a retrospective review of 98 patients in a single centre | |
Susceptibility genes in sporadic ALS: separating the wheat from the chaff by international collaboration. | |
Sustained neurological improvement following reduced-intensity conditioning allogeneic haematopoietic stem cell transplantation for late-onset Krabbe disease | |
Synergistic versus antagonistic actions of glutamate and glutathione: the role of excitotoxicity and oxidative stress in neuronal disease. | |
Tar DNA-binding protein-43 (TDP-43) regulates axon growth in vitro and in vivo | |
Tau levels do not influence human ALS or motor neuron degeneration in the SOD1G93A mouse. | |
TDP-43 causes neurotoxicity and cytoskeletal dysfunction in primary cortical neurons. | |
Too fast or not too fast: the FDA's approval of Merck's HPV vaccine Gardasil | |
Toward a theory of neuroplasticity | |
Transportin 1 colocalization with Fused in Sarcoma | |
U1 snRNP is mislocalized in ALS patient fibroblasts bearing NLS mutations in FUS and is required for motor neuron outgrowth in zebrafish | |
Use of human intravenous immunoglobulin in lower motor neuron syndromes | |
VAPB interacts with the mitochondrial protein PTPIP51 to regulate calcium homeostasis | |
Variants of the elongator protein 3 (ELP3) gene are associated with motor neuron degeneration | |
VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death | |
Volumetric cortical loss in sporadic and familial amyotrophic lateral sclerosis | |
Who profits from uncritical acceptance of biased estimates of vaccine efficacy and safety? | |
Widespread binding of FUS along nascent RNA regulates alternative splicing in the brain | |
Wild type human TDP-43 potentiates ALS-linked mutant TDP-43 driven progressive motor and cortical neuron degeneration with pathological features of ALS. | |
Younger age of onset in familial amyotrophic lateral sclerosis is a result of pathogenic gene variants, rather than ascertainment bias | |
প্রত্যুত্তর |